Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker

被引:0
作者
Min-Shan Tsai
Chao-Hsiun Tang
Chia-Ying Lin
Po-Ya Chuang
Nai-Chuan Chen
Chien-Hua Huang
Wei-Tien Chang
Tzung-Dau Wang
Ping-Hsun Yu
Wen-Jone Chen
机构
[1] National Taiwan University Medical College and Hospital,Department of Emergency Medicine
[2] National Taiwan University Hospital Hsin-Chu Branch,Department of Emergency Medicine
[3] Taipei Medical University,School of Health Care Administration
[4] Ministry of Health and Welfare,Department of Emergency Medicine, Taoyuan General Hospital
[5] National Taiwan University Medical College and Hospital,Division of Cardiology, Department of Internal Medicine
[6] Ministry of Health and Welfare,Department of Emergency Medicine, Taipei Hospital
来源
Cardiovascular Drugs and Therapy | 2017年 / 31卷
关键词
Hypertension; Stroke; Myocardial infarction; Mortality; Taiwan National Health Insurance Research database;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:535 / 543
页数:8
相关论文
共 243 条
[1]  
Ezzati M(2002)Selected major risk factors and global and regional burden of disease Lancet 360 1347-1360
[2]  
Lopez AD(2002)Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 1903-1913
[3]  
Rodgers A(2012)Incidence and prognosis of resistant hypertension in hypertensive patients Circulation 125 1635-1642
[4]  
Vander Hoorn S(2013)Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis Eur Heart J 34 1204-1214
[5]  
Murray CJ(2014)Resistant hypertension and associated comorbidities in a veterans affairs population J Clin Hypertens 16 741-745
[6]  
Lewington S(2015)Resistant hypertension: risk factors, subclinical atherosclerosis, and comorbidities among adults—the Brazilian longitudinal study of adult health (ELSA-Brasil) J Clin Hypertens 17 74-80
[7]  
Clarke R(2002)Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) J Clin Hypertens 4 393-404
[8]  
Qizilbash N(2014)Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Hypertension 64 1012-1021
[9]  
Peto R(2011)Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008 Circulation 124 1046-1058
[10]  
Collins R(2013)The possibility of resistant hypertension during the treatment of hypertensive patients Hyperten Res 36 924-929